|By Business Wire||
|July 10, 2014 03:00 AM EDT||
The PHT Corporation LogPad® System– the world’s most popular electronic patient reported outcome (ePRO) diary – is available on the Google and LG Electronics Nexus smartphone with scanning technology that improves the accuracy of clinical research program medication and supply tracking. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.
PHT selected the Nexus for its state-of-the-art features including scanner technology and 5-inch display screen. The easy-to-use Android platform is an ideal fit for the LogPad System. It provides a better user experience with fast response times and numerous connectivity options. Additionally, sponsor companies can leverage the embedded Android barcode scanning technology to streamline trial processes and improve patient safety monitoring and drug supply tracking. Patient enrollment and provisioning is automated by scanning the specific trial QR code via the smartphone’s scanner. Watch a brief demo: http://bit.ly/LogPadScanner
The ability to scan the barcode on injection-based therapies is especially useful for tracking and managing the drug supply and patient adherence to the medication schedule of expensive drug and biologics. Sponsors studying hemophilia, rheumatoid arthritis, hepatitis C and other indications have expressed strong interest in this capability.
PHT Vice President of Marketing and Product Management Sheila Rocchio, MBA, explained, “The LogPad System on the Nexus smartphone provides greater ease of use for study participants and flexibility in applications for clinical trials.”
Sponsors, clinicians and patients use the LogPad System for ease of use, regulatory compliance, and data integrity. Pharma has used the LogPad System for 18 submissions, 17+ approvals and 14+ PRO label claims to date.
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enables clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.